According to the post-IPO stock option plan of CARSGEN-B (02171), 6.74 million stock options were granted.

date
18/09/2025
avatar
GMT Eight
Kojie Pharmaceutical B (02171) issued an announcement on September 18, 2025, that the company conducted its initial public offering...
CARSGEN-B (02171) announces that on September 18, 2025, the company has granted 6.7405 million share options to 348 option grantees in accordance with the terms of the first public offering of share options plan. However, the share options will only become effective after acceptance by the option grantees. The company has granted share options to reward employees for their past contributions to the company's success, in order to encourage them to further contribute to the company and align their interests with the overall best interests of the company and shareholders. The Board of Directors also announced that on September 18, 2025, the company has granted 1.9115 million restricted share units to 196 restricted share unit grantees in accordance with the terms of the restricted share unit plan after the first public offering. However, the restricted share units will only become effective after acceptance by the restricted share unit grantees. The grant of restricted share units aims to align the interests of eligible individuals with the group's interests by owning shares, in order to encourage and retain them to contribute to the group's long-term growth and profitability.